Full Press Release Details
SAN FRANCISCO , March 6, 2019 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR ) today announced that its Chief Scientific Officer, Jonathan Zalevsky , Ph.D., is scheduled to present at the Cowen and Company 39 th Annual Health Care Conference on Tuesday, March 12, 2019 at 9:20 a.m. Eastern Time .
The presentation will be accessible via a webcast link posted on the Investors section of the Nektar website at http://ir.nektar.com/ . This webcast will be available for replay until April 12, 2019 .
About Nektar Nektar Therapeutics is a research-based, development stage biopharmaceutical company whose mission is to discover and develop innovative medicines to address the unmet medical needs of patients. Our R&D pipeline of new investigational medicines includes treatments for cancer, auto-immune disease and chronic pain. We leverage our proprietary and proven chemistry platform in the discovery and design of our new therapeutic candidates. Nektar is headquartered in San Francisco, California , with additional operations in Huntsville, Alabama and Hyderabad, India . Further information about Nektar and its drug development programs and capabilities may be found online at www.nektar.com .
SOURCE Nektar Therapeutics